ArticleThoracic cancer2024

A study protocol for an open-label, single-arm, single-center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma.

Huiying Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.